Just a reminder that lots of pharmaceutical companies have programs similar to the program for Q. For instance, just saw an ad on TV this morning for Advair, for treatment of COPD symptoms. 1st month free, and discounts for prescription refills. And this after it has been on the market for years for asthama. I don't think GSK is giving it away out of the goodness of their heart, but rather as part of what they expect to be a valuable marketing program.
Just a couple of questions georgebailey;
Is Advair GSK's only drug on the market?
Is GSK Bring in $2 million on Advair and spending $58 million?
Does Advair have 10 post studies to pay for?
Did GSK just take out a 13% loan using Advair's patent for collateral?
Does Advair have generic competition at 1/6 the price?
Is GSK at all hurting for money?
If you answered yes to ALL of these questions then you can make this comparision, otherwise ARE YOU KIDDING ME!
Wait till actual dollar amounts come! (revenue)
Vivus already burned up the first installment of their loan.
With first 2weeks free and a 70% discount for the first month their PRESCRIPTIONS SHIPPED are dismall to say the least.Yet Phen/Top scripts are off the charts!
Vivus is in serious trouble.